These 3 shares are the best performers of the ASX 50 so far in 2021

So far, these 3 shares are the cream of the ASX 50 crop for 2021

| More on:
blue arrows representing a rising share price ASX 200

Image source: Getty Images

While the S&P/ASX 200 Index (ASX: XJO) is a favourite among many market watchers, Australia’s very top companies can also be found in another, more niche index.

The S&P/ASX 50 Index (ASX: XFL) is where you’ll find Australia’s biggest fish. It’s a scoreboard of shares with larger market capitalisations and more liquidity than all others on the ASX.

Today, the ASX 50 is down 0.77%. Though, it’s gained 11.68% since the beginning of the year. That’s ever so slightly better than the ASX 200’s 10.8% year-to-date gain.

And these 3 shares are elbowing out the rest. These are the top performing shares of the ASX 50 so far this year.

2021’s cream of the ASX 50 crop

Aristocrat Leisure Limited (ASX: ALL)

Having gained 38% so far this year, Aristocrat shares are playing an impressive game.

Currently, one share in this ASX 50 bigwig will cost an investor $42.78.

Aristocrat Leasure is a gaming technology company that produces poker machines (pokies) and casino management systems as well as free-to-play digital games.

The company has a market capitalisation of around $27 billion, with approximately 638 million shares outstanding.

Westpac Banking Corp (ASX: WBC)

The banking giant isn’t too far from leading the ASX 50, with the Westpac share price having gained 34.64% since the start of 2021.

Right now, the bank’s shares are trading for $26.08.

Westpac is one of Australia’s big four banks and the oldest bank in the country.

It’s also currently the fourth largest company on the ASX, with a market capitalisation of around $96 billion and approximately 3 billion shares outstanding.

Cochlear Limited (ASX: COH)

The Cochlear share price has gained an impressive 30.85% year to date.

One portion of the company will set an investor back $247.30, making the Cochlear share price among the highest on the ASX.

The company manufactures and sells hearing devices. It’s a global leader in its field, distributing its products to more than 20 countries.

Cochlear has a market capitalisation of around $16 billion, with approximately 65 million shares outstanding.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers